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Background: Cigarette smoking is one of the major factors that increases arterial stiffness. The purpose of this
study was to examine further the relationship between smoking status and arterial stiffness using a new index, the
cardio-ankle vascular index (CAVI), in male Japanese workers.
Methods: This cross-sectional study included 4,729 male Japanese workers undergoing annual health checkups.
CAVI was measured at the time of the annual health checkup between April 2007 and March 2008. The subjects
were divided into three groups, smokers (n = 1,913), former smokers (n = 1,481) and non-smokers (n = 1,348)
according to their responses to a questionnaire. We compared the CAVI in the three groups after adjusting for age.
Multiple regression analysis was used to examine the association between CAVI and the number of cigarettes
smoked per day in order to examine whether there was a dose–response relationship between smoking and CAVI.
Results: The mean CAVI for each group was 7.81 ± 0.02 for smokers, 7.70 ± 0.02 for former smokers and 7.64 ± 0.02
for non-smokers. A significant difference was observed between each group. According to the results of multiple
regression analysis, the standardized β of the number of cigarettes smoked per day was 0.09 (p< 0.01). This
confirmed a positive association with CAVI.
Conclusions: Our study demonstrated that there is a significant association between the number of cigarettes
smoked per day and arterial stiffness, as measured by CAVI.
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Cardiovascular disease is a major cause of death in
industrialized countries [1]. In Japan, too, the rate of car-
diovascular disease as a cause of morbidity has notice-
ably increased with the westernization of lifestyles.
Arterial stiffening is a major factor in cardiovascular dis-
ease because of the reduced capacity in blood vessels
and the concomitant rise in pulse pressure and fall in
shear stress [2]. Therefore, assessment of arterial stiff-
ness is believed to be useful in the prevention of cardio-
vascular disease.* Correspondence: k-hata@med.uoeh-u.ac.jp
1Department of Work Systems and Health, Institute of Industrial Ecological
Science, University of Occupational and Environmental Health, 1-1 Iseigaoka,
Kitakyusyu, 811-4341 Fukuoka, Japan
Full list of author information is available at the end of the article
© 2012 Hata et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the orNon-invasive indices of arteriosclerosis, especially
brachio-ankle pulse wave velocity (baPWV), are com-
monly used for measuring arterial stiffness. An association
has been demonstrated between baPWV values and ar-
teriosclerotic diseases, including cardiovascular disease
[3]. However, baPWV is strongly dependent on the sub-
ject’s blood pressure (BP) at the time of measurement and
it is sometimes difficult to assess the baPWV value during
treatment for hypertension or as a result of ‘white coat‘
hypertension. Recently, the cardio-ankle vascular index
(CAVI), a new convenient method of non-invasive meas-
urement, has been introduced to assess arterial stiffness.
CAVI was developed by measuring PWV from the heart
to the ankle, as well as BP [4]. CAVI represents arterial
stiffness, specifically the elastic properties of the arterial
wall between the aortic arch and distal arteries of thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is associated with atherosclerotic disease and particularly
reflects arteriosclerosis of the aorta, femoral and tibial ar-
teries [4-6]. One of CAVI’s greatest merits is that measure-
ments remain essentially unaffected by BP, in contrast to
other non-invasive parameters of arterial stiffness [7].
Some studies in Japan suggested that chronic smoking
affects arterial stiffness [8,9]. Cigarette smoking induces
changes in both peripheral and central vascular function,
even in young or middle aged smokers [10]. However,
there are few large-scale studies on the relationship be-
tween smoking status and arterial stiffness in subjects of
working age. In this cross-sectional study, we examined
whether there was an association between smoking sta-
tus and arterial stiffness, as measured by CAVI, and




Study subjects were participants in annual health exami-
nations conducted between April 2007 and March 2008
by a Japanese electrical machinery manufacturing com-
pany who requested a CAVI assessment of arterial stiff-
ness. CAVI examinations were performed in 4,831 male
workers in a fasting state. Workers whose CAVI values
were taken after a meal (n = 5) or were unreliable (six
with ankle brachial index (ABI) <0.9, 65 with arrhythmia
[4]) or could only be measured on one side (n = 23), as
well as any workers who declined to provide information
on their smoking status (n = 3), were excluded from our
study. Finally, a total of 4,729 subjects were selected.
Written informed consent was obtained from each
examinee regarding the use of his data for research pur-
poses prior to the study. This study was approved by the
ethics committee of Hitachi General Hospital.
Cardio-ankle vascular index
CAVI was measured by trained technicians using VaSera
VS-1000 (Fukuda Denshi, Tokyo, Japan). Cuffs were
placed bilaterally on the upper arms and ankles while
the subjects were lying in a supine position with their
heads held along the midline. Electrocardiography elec-
trodes were placed on both wrists and a microphone
was placed to detect heart sounds over the sternum. The
participants rested in this supine position before moni-
toring commenced. The CAVI was calculated using the
formula:
CAVI ¼ 2ρ ln Ps=Pdð Þ  PWV2=ΔP
where Ps is systolic BP (SBP); Pd is diastolic BP
(DBP);ΔP is SBP-DBP;ρis blood density; and PWV is
pulse wave velocity. PWV was measured from the aorticvalve to the ankle. Detailed CAVI measurement methods
and principles have been previously reported [4]. All
these measurements and calculations were performed
automatically. The mean bilateral CAVI was used in our
analysis. ABI was measured at the same time.
Laboratory data
Height and weight were measured using an automated
scale (Tanita BF-220, Tokyo, Japan) with the participants
wearing a light gown. Body mass index (BMI) was calcu-
lated as the weight in kilograms divided by the square of
height in meters. Other laboratory data obtained were
glycosylated hemoglobin (HbA1c), blood sugar, total
cholesterol, low-density lipoprotein (LDL) cholesterol,
high-density lipoprotein (HDL) cholesterol and triglycer-
ides in the fasting state.
Blood pressure measurement
BP was measured by trained nurses with participants in
the sitting position after sufficient rest. Pulse rate was
measured at the same time. If SBP was over 140 mmHg
or DBP was over 90 mmHg, BP was measured again.
We used the ES-H55 (Terumo, Tokyo, Japan) to meas-
ure BP.
Questionnaire
A self-administered questionnaire was used to collect in-
formation on smoking status (smoker, former smoker,
non-smoker), the average number of cigarettes smoked
per day (or previously smoked for former smokers), his-
tory of treatment for lifestyle diseases (diabetes mellitus,
high BP, dyslipidemia) and average alcohol consumption
per week. Average alcohol consumption per week was
assessed by “go” in this study. A “go” is a traditional
Japanese unit consisting of 23 g ethanol.
Statistical analysis
Statistical analysis was performed using SPSS Version 15
for Windows (SPSS, Chicago, USA). Continuous and cat-
egorical data are expressed as mean± standard deviation
(SD) and number (percentage), respectively. A p-value
< 0.05 was considered statistically significant. Baseline
characteristics of the participants were compared by
Tukey’s t-test. We compared the mean CAVI among the
three groups: smokers, former smokers and non-smokers.
However, non-invasive parameters of arterial stiffness, in-
cluding CAVI, are strongly dependent on age. Therefore,
data were compared as mean±SD adjusted for age by
analysis of covariance (ANCOVA). In addition, multiple
stepwise regression analysis was performed to examine
the relation between average number of cigarettes smoked
per day and CAVI. Dependent variables were 1) age; 2)
BMI; 3) average number of cigarettes smoked per day; 4)
SBP; 5) DBP; 6) pulse rate; 7) LDL cholesterol; 8) HDL
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HbA1c; 12) alcohol consumption (the amount of “go”
consumed per week).
Results
The 4,729 subjects consisted of 1,907 smokers, 1,479
former smokers and 1,343 non-smokers. Baseline charac-
teristics of the participants are shown in Table 1. The aver-
age ages of non-smokers, former smokers and smokers
were 48.5± 8.6 years, 51.6 ± 7.5 years and 48.7± 8.1 years,
respectively. Former smokers were significantly older than
subjects belonging to the other two groups, but there was
no significant difference between smokers and non-
smokers (former smoker versus non-smoker: p < 0.01;
former smoker versus smoker: p< 0.01; smoker versus
non-smoker: p=0.77). Non-smokers had significantly
higher HDL-cholesterol (p< 0.01), SBP (p< 0.01) and
DBP (p < 0.01) than smokers and significantly lower tri-
glyceride (p< 0.01) and HbA1c (p < 0.01). Weekly alcoholTable 1 Baseline characteristics of 4,729 male Japanese
workers in this study between April 2007 and March







Age (year) 48.5 ± 8.6 51.6 ± 7.5* 48.7 ± 8.1
Body Mass Index 24.3 ± 3.1* 24.3 ± 2.8* 24.0 ± 3.2
Blood pressure (mmHg)
Systolic 121.5 ± 11.5* 122.7 ± 11.1* 118.9 ± 12.1
Diastolic 77.8 ± 8.0* 78.8 ± 7.6* 76.1 ± 8.3
Pulse rate (per minute) 68.9 ± 10.0 69.0 ± 9.8 68.2 ± 9.1
Fasting serum cholesterol (mg/dl)
Low-density lipoprotein 126.0 ± 27.7 125.6 ± 27.7 124.6 ± 30.9
High-density lipoprotein 57.0 ± 13.7* 56.9 ± 14.3* 52.6 ± 13.1
Triglycerides 112.3 ± 1.6* 118.1 ± 1.7* 129.2 ± 1.7
Glucose (mg/dl) 104.3 ± 17.0 108.3 ± 22.7* 105.5 ± 21.5
Hemoglobin A1c (%) 5.4 ± 0.6* 5.5 ± 0.8 5.5 ± 0.8
Alcohol consumption
(“go”/week)
3.86 ± 4.7* 6.11 ± 5.5* 5.91 ± 5.9
Number of cigarettes
smoked per day
19.4 ± 8.5 19.0 ± 6.5
Under medical treatment (n (%))
High blood pressure 150 (11.2 %) 269 (18.2 %)* 209 (11 %)
Dyslipidemia 86 (6.4 %) 155 (10.5 %)* 125 (6.6 %)
Diabetes mellitus 43 (3.2 %)* 95 (6.4 %) 95 (5 %)
Values are mean ± standard deviation or n (%).
The logarithmic mean of triglycerides was examined. High blood pressure was
defined as > 140/90 mmHg (Japanese Society of Hypertension: Guidelines for
the Management of Hypertension 2009).
Number of cigarettes smoked per day in former smoker: Number of cigarettes
smoked per day when they were smokers.
*: p-value < 0.05 compared with smokers by Tukey's t-test or the Chi-square
test.consumption was significantly lower for non-smokers
than for the other two groups (non-smoker versus former
smoker: p< 0.01, non-smoker versus smoker: p < 0.01).
Figure 1 shows the distribution of the average number
of cigarettes smoked per day among smokers. The high-
est smoking frequency was an average number of 16 to
20 cigarettes per day. The frequency of more than 40
cigarettes per day was extremely low.
The CAVI data among smokers, non-smokers and ex-
smokers are presented in Figure 2. We used ANCOVA
to adjust for the influence of age. The average CAVI of
all participants was 7.73. The CAVI of smokers, ex-
smokers and non-smokers was 7.81 ± 0.02, 7.70 ± 0.02
and 7.64 ± 0.02, respectively. A significant difference was
observed for each group (non-smoker versus former
smoker: p < 0.01, non-smoker versus smoker: p < 0.01,
former smoker versus smoker: p= 0.047).
Table 2 shows the result of stepwise multiple regres-
sion analysis between non-smokers and smokers. Age
was the strongest factor that affected CAVI (β: 0.05,
95 % confidence interval (CI) of β: 0.05–0.056, p < 0.01).
After adjustment for age, the average number of cigar-
ettes smoked per day had the greatest influence on
CAVI (β: 0.11, 95 % CI of β: 0.08-0.14, p < 0.01).
Discussion
The study indicated that CAVI, the new index of arterial
stiffness, differs significantly after adjustment for age in
Japanese male workers, depending on their smoking sta-
tus. Many studies have reported that smoking status
affects the non-invasive index of arterial stiffness or ar-
teriosclerosis [8,9]. In addition, previous studies showed
that the average number of cigarettes smoked per day
influenced arterial stiffness [11]. We were able to con-
firm these relationships by using CAVI, which is the new
index of arterial stiffness.
Various studies have also shown that smoking plays a
major role in the occurrence of arteriosclerosis and ar-
teriosclerotic disease [12-16]. Smoking promotes arterio-
sclerosis because it induces nitric oxide damage to
vascular endothelial cells, contributes to high BP or dia-
betes mellitus, and stimulates coagulation and fibrinoly-
sis pathways [17]. Arterial stiffness is thought to be
associated with arteriosclerosis. However, it is ethically
difficult to measure arteriosclerosis by invasive methods.
CAVI measures arterial stiffness noninvasively and con-
veniently, and this advantage makes CAVI an appropri-
ate method for assessment of arteriosclerosis caused by
smoking in working people.
The CAVI of former smokers was lower than that of
smokers but higher than that of non-smokers. Smoking
cessation would not result in an immediate restoration
of CAVI to non-smoker levels. It was shown that it took
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Figure 1 Smoking Frequency by number of cigarettes Smoked per day.
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tween the mortality rates of non-smokers and former
smokers 10–14 years after smoking cessation [18]. Simi-
larly, most other improvements in CAVI as a result of
smoking cessation may take a long time.
The Brinkman index (the number of cigarettes smoked
per day multiplied by the number of years of smoking) is
commonly used to estimate the cumulative dose of
smoking. In this study, however, we thought age would
impact the Brinkman index and, therefore, we used the
number of cigarettes smoked per day for our analysis.
Our study has several limitations. First, it is a cross-
sectional study. A cohort study is required to accurately














Figure 2 CAVI in Each Smoking Status Analysis of covariance (ANCOV
±SD of non-smokers, former smokers and smokers adjust by age are 7.64±the subjects’ CAVI and obtain information on their smok-
ing status at annual health checkups. Another limitation
was the fact that all study subjects were male workers and
thus our findings cannot be applied to women. There may
be differences between men and women in CAVI due to
lifestyle or disease and therefore it is necessary to conduct
studies that include female subjects to determine any dis-
tinction between the genders.
Conclusions
Our study showed an association between smoking sta-
tus and CAVI in Japanese male workers. CAVI was
higher in smokers than in non-smokers and ex-smokers
adjusted for age. In addition, the number of cigarettes*
*
okers smokers
A) was performed to adjust for age *:P value <0.01. Mean CAVI
0.02 and 7.81 ± 0.02 respectively.
Table 2 Results of multiple linear regression analysis conducted to assess the relationship of CAVI to measures of
variables in non-smoking group and smoking group (n =3,250)
β 95%CI of β Standardized β p
Age (actual age) 0.05 0.05–0.056 0.50 < 0.01
Number of cigarettes smoked per day (actual number) 0.11 0.08–0.14 0.09 < 0.01
R square 0.45
Adjusted R square 0.45
Dependent variables were 1) age; 2) body mass index; 3) average number of cigarettes smoked per day; 4) systolic blood pressure; 5) diastolic blood pressure; 6)
pulse rate; 7) low-density lipoprotein cholesterol; 8) high-density lipoprotein cholesterol; 9) triglycerides; 10) total cholesterol; 11) HbA1c; 12) alcohol consumption
(amount of “go” consumed per week). CI, confidence interval.
Stepwise procedures were used in this analysis.
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ness, as measured by CAVI.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KH, TN and TH contributed to data collection. KH and TN contributed to
data analysis. KH, MM, HK, and AK interpreted the data, and wrote the
manuscript. All authors read and approved the final manuscript.
Acknowledgments
This work was supported, in part, by Sompo Japan Research Institute Inc.
Author details
1Department of Work Systems and Health, Institute of Industrial Ecological
Science, University of Occupational and Environmental Health, 1-1 Iseigaoka,
Kitakyusyu, 811-4341 Fukuoka, Japan. 2Hitachi Health Care Center, Hitachi
Ltd., 4-3-16 Osecho, Hitachi 317-0076, Ibaraki, Japan.
Received: 1 May 2012 Accepted: 16 July 2012
Published: 28 July 2012
References
1. Murray CJ, Lopez AD: Alternative projections of mortality and disability
by cause 1990–2020: Global Burden of Disease Study. Lancet 1997,
349:1498–1504.
2. O'Rourke MF, Hashimoto J: Mechanical factors in arterial aging: a clinical
perspective. JACC 2007, 50:1–13.
3. Kubo T, Miyata M, Minagoe S, Setoyama S, Maruyama I, Tei C: A simple
oscillometric technique for determining new indices of arterial
distensibility. Hypertens Res 2002, 25:351–358.
4. Shirai K, Utino J, Otsuka K, Takata M: A novel blood pressure-independent
arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).
J Atheroscler Thromb 2006, 13:101–107.
5. Yambe T, Meng X, Hou X, Wang Q, Sekine K, Shiraishi Y, Watanabe M,
Yamaguchi T, Shibata M, Kuwayama T, Murayam M, Konno S, Nitta S:
Cardio-ankle vascular index (CAVI) for the monitoring of the
atherosclerosis after heart transplantation. Biomed Pharmacother 2005,
59(Suppl 1):S177–S179.
6. Kadota K, Takamura N, Aoyagi K, Yamasaki H, Usa T, Nakazato M, Maeda T,
Wada M, Nakashima K, Abe K, Takeshima F, Ozono Y: Availability of cardio-
ankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ J
2008, 72:304–308.
7. Izuhara M, Shioji K, Kadota S, Baba O, Takeuchi Y, Uegaito T, Mutsuo S,
Matsuda M: Relationship of Cardio-Ankle Vascular Index (CAVI) to Carotid
and Coronary Arteriosclerosis. Circ J 2008, 72:1762–1767.
8. Yufu K, Takahashi N, Hara M, Saikawa T, Yoshimatsu H: Measurement of the
brachial-ankle pulse wave velocity and flow-mediated dilatation in
young, healthy smokers. Hypertens Res 2007, 30:607–612.
9. Tomiyama H, Yamazaki M, Sagawa Y, Teraoka K, Shirota T, Miyawaki Y,
Yamashina A: Synergistic effect of smoking and blood pressure on
augmentation index in men, but not in women. Hypertens Res 2009,
32:122–126.10. Wiesmann F, Petersen SE, Leeson PM, Francis JM, Robson MD, Wang Q,
Choudhury R, Channon KM, Neubauer S: Global impairment of brachial,
carotid, and aortic vascular function in young smokers: direct
quantification by high-resolution magnetic resonance imaging. J Am Coll
Cardiol 2004, 44:2056–2064.
11. Virtanen MP, Koobi T, Turjanmaa VM, Majahalme S, Tuomisto MT, Nieminen
T, Kahonen M: Predicting arterial stiffness with ambulatory blood
pressure: an 11-year follow-up. Clin Physiol Funct Imaging 2008,
28:378–383.
12. Seltzer CC: Framingham study data and "established wisdom" about
cigarette smoking and coronary heart disease. JCE 1989, 42:743–750.
13. Kiyohara Y, Ueda K, Fujishima M: Smoking and Cardiovascular-Disease in
the General-Population in Japan. J Hypertens 1990, 8:S9–S15.
14. Shimozato M, Nakayama T, Yokoyama T, Yoshi-ike N, Yamaguchi M, Date C:
A 15.5-year cohort study on risk factors for possible myocardial
infarction and sudden death within 24 hours in a rural Japanese
community. J Epidemiol 1996, 6:15–22.
15. Shimamoto T, Komachi Y, Inada H, Doi M, Iso H, Sato S, Kitamura A, Iida M,
Konishi M, Nakanishi N: Trends for coronary heart disease and stroke and
their risk factors in Japan. Circulation 1989, 79:503–515.
16. Konishi M, Iso H, Iida M, Naito Y, Sato S, Komachi Y, Shimamoto T, Doi M,
Ito M: Trends for coronary heart disease and its risk factors in Japan:
epidemiologic and pathologic studies. Jpn Circ J 1990, 54:428–435.
17. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF:
Systemic effects of smoking. Chest 2007, 131:1557–1566.
18. Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S, Koizumi A,
Wada Y, Kondo T, Inaba Y, Tamakoshi A: Smoking cessation and mortality
from cardiovascular disease among Japanese men and women: the
JACC Study. Am J Epidemiol 2005, 161:170–179.
doi:10.1186/1617-9625-10-11
Cite this article as: Hata et al.: Relationship between smoking and a new
index of arterial stiffness, the cardio-ankle vascular index, in male
workers: a cross-sectional study. Tobacco Induced Diseases 2012 10:11.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
